Reps. Beth Liston (D-Dublin) and Gayle Manning (R-North Ridgeville) introduced House Bill (HB) 305, the Insulin Affordability Act, to address the issue of insulin pricing in Ohio.
The legislation would cap the price of insulin provided by health plans at no more than $35 for a 30-day supply. This price aligns with the price of insulin for those insured by Medicare Part D Plans.
“For many, insulin is as necessary as water or air,” said Rep. Liston. “No one should die because they cannot afford this critical medicine.”
Insulin prices nearly doubled from 2012 to 2016, and one in four diabetes patients have had to ration their life-saving medication due to cost.
Eight other states have already passed insulin cost-capping bills, and many others have introduced similar legislation.
HB 305 now awaits referral to a House committee.